Lv3
260 积分 2025-10-17 加入
DEVELOPMENT OF A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL TO PREDICT PLASMA AND BRAIN EXPOSURE FOLLOWING ADMINISTRATION OF VALPROIC ACID AND CLOBAZAM IN COMBINATION TREATMENT REGIMEN FOR DRAVET SYNDROME IN CHILDREN
2天前
已完结
A physiologically-based pharmacokinetic model for the antibiotic ertapenem
3天前
已完结
In vitroandin vivopharmacokinetic characterization of mavacamten, a first-in-class small molecule allosteric modulator of beta cardiac myosin
6天前
已完结
Physiologically based pharmacokinetic modeling of aldehyde oxidase drug-drug interactions mediated by erlotinib
6天前
已关闭
iMSEA: A Novel Metabolite Set Enrichment Analysis Strategy to Decipher Drug Interactions
6天前
已完结
Demonstration of Interaction between Carbapenem Group Antibiotics andDifferent Immunosuppressant Drugs by Molecular Docking
11天前
已完结
Physiologically based pharmacokinetic modeling of ponatinib to describe drug–drug interactions in patients with cancer
11天前
已完结
Evaluating the Effects of Ertapenem and Meropenem on Tacrolimus
12天前
已完结
PBPK modelling for the evaluation of drug–drug interaction between meropenem and valproic acid
13天前
已完结
The Effect of Carbapenem Antibiotics on Plasma Concentrations of Valproic Acid
13天前
已完结
皖公网安备34019202002308
